Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lab21 secures £2.2m for expansion

This article was originally published in Clinica

Executive Summary

Lab21's international growth plans have picked up momentum after the Cambridge, UK-based company raised £2.2m ($3.3m) in the first tranche of an over-£10m financing round. The funds came from two new investors – US-based Nexus Medical Partners and Rowan Dartington in the UK – as well as existing shareholder Merlin Biosciences. Lab21 will use the new capital to consolidate its presence in the North American market by establishing a base in South Carolina. In addition, the funds will go towards closing a series of planned acquisitions to grow Lab21's technology and commercialisation capabilities, CEO Graham Mullis told Clinica. The company expects to complete two acquisition deals in Europe during the first half of 2009.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042227

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel